Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
-
Published:2017-01-24
Issue:2
Volume:12
Page:263-263
-
ISSN:1776-2596
-
Container-title:Targeted Oncology
-
language:en
-
Short-container-title:Targ Oncol
Author:
Shi Yi,Sun Lin,Chen Ge,Zheng Dongyan,Li Li,Wei Wanguo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology